.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Cipla
Deloitte
Mallinckrodt
Federal Trade Commission
Chubb
US Army
Teva
Cerilliant
AstraZeneca

Generated: July 21, 2017

DrugPatentWatch Database Preview

Cimetidine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cimetidine hydrochloride and what is the scope of cimetidine hydrochloride freedom to operate?

Cimetidine hydrochloride
is the generic ingredient in four branded drugs marketed by Vintage Pharms Llc, Ani Pharms Inc, Hospira, Glaxosmithkline, Dava Pharms Inc, Cycle Pharms Ltd, Teva Parenteral, Luitpold, Pharm Assoc, Wockhardt, Apotex Inc, Hi Tech Pharma, and G And W Labs Inc, and is included in twenty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for cimetidine hydrochloride. Two suppliers are listed for this compound.

Summary for Generic Name: cimetidine hydrochloride

Tradenames:4
Patents:1
Applicants:13
NDAs:24
Drug Master File Entries: see list25
Suppliers / Packagers: see list2
Bulk Api Vendors: see list18
Clinical Trials: see list2,293
Patent Applications: see list1,084
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cimetidine hydrochloride at DailyMed

Pharmacology for Ingredient: cimetidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
SOLUTION;ORAL074610-001Sep 26, 1996AARXNoNo► Subscribe► Subscribe
Ani Pharms Inc
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
SOLUTION;ORAL074859-001Jul 9, 1998DISCNNoNo► Subscribe► Subscribe
Hospira
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
INJECTABLE;INJECTION074345-001Jan 31, 1995DISCNNoNo► Subscribe► Subscribe
G And W Labs Inc
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
SOLUTION;ORAL074176-001Jun 1, 1994DISCNNoNo► Subscribe► Subscribe
Glaxosmithkline
TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cimetidine hydrochloride
INJECTABLE;INJECTION019434-001Oct 31, 1985DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cimetidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cimetidine hydrochloride
INJECTABLE;INJECTION019434-001Oct 31, 19854,024,271► Subscribe
Glaxosmithkline
TAGAMET
cimetidine hydrochloride
INJECTABLE;INJECTION017939-002Approved Prior to Jan 1, 19823,950,333► Subscribe
Glaxosmithkline
TAGAMET
cimetidine hydrochloride
SOLUTION;ORAL017924-001Approved Prior to Jan 1, 19823,950,333► Subscribe
Glaxosmithkline
TAGAMET
cimetidine hydrochloride
INJECTABLE;INJECTION017939-002Approved Prior to Jan 1, 19824,024,271► Subscribe
Glaxosmithkline
TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cimetidine hydrochloride
INJECTABLE;INJECTION019434-001Oct 31, 19853,950,333► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Julphar
Daiichi Sankyo
Chubb
Baxter
Argus Health
Cerilliant
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot